Macranthoidin B is a major bioactive saponin in rat plasma after oral administration of extraction of saponins from Flos Lonicerae.
体外研究
Macranthoidin B (0-500 μM; 24 h) can inhibit the migration and invasion of primary endometriosis stromal cells and HEC1-B endometrial cancer cells, as well as suppress epithelial mesenchymal transition and COX-2/PGE2 pathway.
Macranthoidin B (20-400 μM; 24-48 h) dose dependently reduces the survival rate of HCT-116 colorectal cancer cells, induces cell apoptosis, and promotes ROS generation.
Macranthoidin B (20-400 μM; 48 h) can dose dependently promote ROS generation in HCT-116 colorectal cancer cells.
Macranthoidin B (20-400 μM; 48 h) can dose dependently downregulate the mRNA expression of antioxidant enzymes MnSOD and GSH Px in HCT-116 colorectal cancer cells.
Macranthoidin B (100-400 μM; 24 h) can dose dependently inhibit Hepa1-6 cell proliferation and increase intracellular ROS levels.
Macranthoidin B (100-400 μM; 24 h) can dose dependently induce oxidative stress in Hepa1-6 cells, manifested by a significant increase in MDA levels and a significant decrease in GSH levels, SOD activity, and GSH Px activity at all tested concentrations.
Cell Viability Assay
Cell Line:
HCT-116 colorectal cancer cells
Concentration:
20, 50, 100, 200, 400 μM
Incubation Time:
48 hours
Result:
Caused a dose-dependent decrease in cell viability, with significant reductions observed at all tested concentrations relative to control.
Western Blot Analysis
Cell Line:
HCT-116 colorectal cancer cells
Concentration:
20, 50, 100, 200, 400 μM
Incubation Time:
72 hours
Result:
Altered caspase-3 expression, increasing levels of cleaved caspase-3 in a dose-dependent manner.
体内研究
Macranthoidin B (3-27 mg/kg; gavage; Daily; 28 days) can inhibit the growth of ectopic lesions in a rat model of endometriosis after autologous transplantation.
Macranthoidin B (16 mg/kg; intraperitoneal injection; Once a day; Lasting for 3 weeks, it can significantly inhibit the growth of nude mouse colorectal cancer xenografts by inducing tumor cell apoptosis.
Reduced post-treatment ectopic endometrial volume compared to pretreatment.
Resulted in transplants with less adhesion and fewer surface blood vessels (9 and 27 mg/kg doses).
Improved pathological morphology of ectopic tissues, with fewer and smaller pseudo glands, reduced microvascularity, and decreased inflammatory cell infiltrations.
Decreased serum estradiol (E2) levels and increased serum progesterone (PROG) levels compared to the untreated endometriosis group.
Increased mRNA and protein expression of epithelial marker Cdh1/E-cadherin in ectopic tissues.
Decreased mRNA expression of mesenchymal markers Cdh2, Vim, Twist, Slug, Snail, Zeb1, and Zeb2, as well as protein expression of mesenchymal markers N-cadherin and Vimentin in ectopic tissues.
Reduced mRNA expression of Ptgs2 and Ptges, and decreased protein levels of COX-2 and PGE2 in ectopic tissues.
Animal Model:
Nude mice (4 weeks old; half male, half female; engrafted with human HCT-116 colorectal cancer cells)
Dosage:
16 mg/kg
Administration:
i.p.; once daily; 3 weeks
Result:
Reduced tumor volume significantly compared to vehicle control.
Reduced tumor weight significantly compared to vehicle control.
Increased TUNEL-positive cells per field significantly compared to vehicle control.
Elevated levels of cleaved caspase-3 compared to vehicle control.
分子式
C65H106O32
分子量
1399.52
CAS号
136849-88-2
中文名称
灰毡毛忍冬皂苷乙;灰毡毛忍冬皂苷 B
运输条件
Room temperature in continental US; may vary elsewhere.